INS and Hyperinsulinemia: However, because 20 and 52 week of CANA treatment did not affect serum insulin levels and/or Akt activity in the liver, improvement of hyperinsulinemia does not appear to be a main or direct mechanism to attenuate hepatocellular carcinogenesis in the present study.